Preclinical Data of Arcellx’s Novel Synthetic CAR-T Binding Domain Presented at the 2021 ASGCT Annual Meeting and the 2021 PEGS Summit
Novel synthetic binding domain used in CART-ddBCMA demonstrates potent anti-tumor activity Results underpin Arcellx’s ongoing…